Free Trial
ASX:BIT

Biotron (BIT) Stock Price, News & Analysis

Biotron logo

About Biotron Stock (ASX:BIT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.03 million shs
Average Volume
N/A
Market Capitalization
$9.93 million
P/E Ratio
N/A
Dividend Yield
5.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.

Receive BIT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter.

BIT Stock News Headlines

Trump’s Secret Social Security Plan?
In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.
See More Headlines

BIT Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotron investors own include TPG Co. Limited (TPM.AX) (TPM), Gemfields Group (GEM), Northern Star Resources (NST), Nokia Oyj (NOK), Mesoblast (MESO), MARA (MARA) and FYI Resources (FYI).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:BIT
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,440,000.00
Net Margins
-208.89%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.65 million
Price / Cash Flow
6.71
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$9.93 million
Optionable
Not Optionable
Beta
-0.61
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (ASX:BIT) was last updated on 4/28/2025 by MarketBeat.com Staff
From Our Partners